What fluid should be used to dilute norepinephrine (noradrenaline) for infusion, and what fluid should be used to dilute Actrapid (regular insulin) for infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fluid Selection for Noradrenaline and Actrapid Infusions

Noradrenaline should be diluted in 5% dextrose (D5W) or 5% dextrose with sodium chloride, while Actrapid (regular insulin) should be diluted in 0.9% normal saline.

Noradrenaline (Norepinephrine) Dilution

The FDA-approved drug label explicitly states that norepinephrine must be diluted in dextrose-containing solutions 1. The label specifies:

  • Dilute in 5% dextrose injection OR 5% dextrose and sodium chloride injections
  • Administration in saline solution alone is NOT recommended 1

The rationale is critical: dextrose-containing fluids provide protection against significant loss of potency due to oxidation 1. This is not merely a preference but a stability requirement.

Standard Dilution Protocol

The FDA label recommends adding 4 mg/4 mL of norepinephrine to 1,000 mL of 5% dextrose-containing solution, yielding 4 mcg/mL 1. Research confirms that norepinephrine solutions at concentrations of 4 mcg/mL and 16 mcg/mL remain chemically stable for seven days at room temperature in both D5W and normal saline 2. However, the FDA label takes precedence, and dextrose solutions should be used to prevent oxidation-related potency loss.

Important Caveat

While research shows stability in normal saline 2, the FDA explicitly advises against saline-only preparations 1. In clinical practice, follow the drug label: use D5W or D5W with sodium chloride.

Actrapid (Regular Insulin) Dilution

Regular insulin (Actrapid) should be diluted in 0.9% normal saline for infusion 3. The 2025 ADA Standards of Care for diabetes management in hospitals provides clear guidance on insulin infusion preparation for diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS) 3.

Standard Dilution Protocol

The guideline describes insulin infusions being prepared with normal saline (0.9% NaCl) as the diluent 3. When transitioning from IV to subcutaneous insulin, the protocol consistently references saline-based preparations.

Why Not Dextrose for Insulin?

Unlike norepinephrine, insulin does not require dextrose for stability. In fact, dextrose is added separately to the IV fluids (not mixed with insulin) once blood glucose drops to target ranges during DKA/HHS treatment 3. The guideline specifies: "When glucose reaches 200 mg/dL in DKA or 250-300 mg/dL in HHS, change to 0.9% NaCl/crystalloid with dextrose" - but this refers to the maintenance fluid line, not the insulin infusion itself 3.

Clinical Pitfalls to Avoid

  1. Never dilute norepinephrine in saline alone - this violates FDA guidance and risks potency loss 1

  2. Do not confuse the maintenance fluid with the drug diluent - for insulin infusions, dextrose is added to the separate maintenance IV line, not to the insulin preparation itself 3

  3. For norepinephrine extravasation: Have phentolamine available (0.1-0.2 mg/kg up to 10 mg diluted in 10 mL of 0.9% sodium chloride) for intradermal injection at the extravasation site 4

  4. Central line preferred for norepinephrine but peripheral administration of dilute norepinephrine (10-20 µg/mL) carries low risk (approximately 0.035% extravasation rate with zero complications requiring intervention in a large multicenter study) 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.